HealthQuill Veozah
US-breast-biopsy
Drugs Health Pharma

FDA issues black box warning for Veozah, hormone-free treatment for hot flashes

Bharti Jayshankar December 19, 2024: The U.S. Food and Drug Administration (FDA) has issued a black box warning for Veozah, a medication designed.

Read More
Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.
Drugs Health Pharma

FDA warning on Veozah: Liver injury risk linked to menopausal drug

HQ Team September 13, 2024: The U.S. Food and Drug Administration (FDA) has issued a safety warning about Veozah (fezolinetant), a medication prescribed.

Read More
Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment of hot flushes in menopausal women.
Drugs Health Pharma

Astellas drug to treat menopausal hot flashes gets FDA’s green light

HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.

Read More